Enhancement of Vasoreactivity andCognition by Intranasal Insulin in Type 2 Diabetes

Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer’s Disease Dementia

Intranasal insulin: is there a promise for treatment of diabetes-related cognitive decline?

Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

Intranasal Insulin Enhanced Resting-State Functional Connectivity of Hippocampal Regions in Type 2 Diabetes

Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration

Effect of intranasally administered insulin on cerebral blood flow and perfusion; a randomized experiment in young and older adults

Intranasal insulin improves cognition and modulates β-amyloid in early AD

A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study

Kurve Active Project List
Dosing in Humans.
Read more...

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
Phase II
Read more...

Superior deposition in gamma scintigraphy studies
Gamma scintigraphy studies have confirmed Controlled Particle Dispersion's unique ability to saturate the entire nasal cavity, including the olfactory regions and the paranasal sinuses. Read more...

Clinical efficacy in Alzheimer's study
Insulin delivered by ViaNase shows promise for patients with Alzheimer’s and Mild Cognitive Impairment. Read more

Live virus potency maintained in CDC study

Download a technical brochure on Controlled Particle Dispersion